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An Association Study of 22 Candidate Genes in
Psoriasis Families Reveals Shared Genetic Factors
with Other Autoimmune and Skin Disorders
Tiphaine Oudot1, Fabienne Lesueur1,2, Mickae¨l Guedj3, Rafael de Cid1, Steven McGinn1, Simon Heath1,
Mario Foglio1, Bernard Prum3, Mark Lathrop1, Jean-Franc¸ois Prud’homme4 and Judith Fischer1
Psoriasis is a common inflammatory and hyperproliferative skin disease. Recent studies have reported that
common genetic factors may underlie both skin and immune-mediated disorders. We hypothesized that such
genes may be involved in susceptibility to psoriasis, and undertook an association analysis of 22 candidate
genes in a set of French high-risk psoriasis families. One hundred fifty-three single-nucleotide polymorphisms
(SNPs) were genotyped and the transmission of alleles in nuclear families was analyzed using the FBAT (family-
based association test). To further investigate suggestive associations, LNM (logistic-normal models) and MQLS
(modified quasi-likelihood score) methods, which take the whole pedigree structure information of families
into consideration, were also applied. Our study supported the involvement of six candidate genes in
susceptibility to psoriasis: SCL12A8, which belongs to the solute carrier gene family; FLG and TGM5, which are
involved in epidermal differentiation; CARD15 and CYLD, which modulate the transcription factor NF-kB; and
IL1RN, which encodes an IL receptor antagonist. Furthermore, we found evidence for interaction between the
major risk allele, HLA-Cw6, and CARD15, CYLD, and TGM5 susceptibility alleles. Taken together, our data show
that shared genetic factors may contribute to the etiology of both psoriasis and other skin or immune-mediated
disorders.
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INTRODUCTION
Psoriasis (MIM 177900) is a hyperproliferative and chronic
inflammatory skin disease that affects approximately 2% of
the world population (Griffiths et al., 2004) and up to 4% of
the Caucasian population (Nevitt and Hutchinson, 1996).
Red scaly plaques, generally occurring on the elbows, knees,
scalp, and lower back, characterize the most common form
of psoriasis, known as psoriasis vulgaris. The disease is
caused by abnormal proliferation and differentiation of epi-
dermal keratinocytes and also by the infiltration of inflam-
matory cells within the lesions, in particular the activated
T cells (Gottlieb et al., 1991; Menter, 1998; Prinz, 2003).
This common immune-mediated disorder involves both
genetic and environmental risk factors (Bowcock and
Cookson, 2004). The pathophysiological overlaps between
diverse autoimmune diseases and the co-occurrence of some
of them in some families suggest the existence of common
etiological mechanisms, and notably a shared genetic back-
ground. For instance, psoriasis vulgaris has been found to
occur together with other inflammatory diseases, such as
psoriatic arthritis (PsA) (Gladman, 1994; Natl. Psoriasis
Found. Bull., 2002) or Crohn’s disease (CD) (Yates et al.,
1982; Lee et al., 1990). To identify the genetic basis of
immune disorders, several genome-wide linkage studies have
been undertaken, which have shown non-random clustering
of susceptibility loci for these diseases, notably the HLA region
on chromosome 6p21 (Yamada and Yamamoto, 2005).
With regard to susceptibility to psoriasis, linkage and
association studies at the PSORS1 locus on 6p21 identified
HLA-Cw6 as the major disease allele (Elder, 2006; Nair et al.,
2006). This allele contributes to the familial clustering (l)
to 33o l o50% (Trembath et al., 1997; The International
Psoriasis Genetics Study, 2003), which indicates that other
susceptibility genes are likely to exist. Genome-wide linkage
scans for psoriasis have highlighted potential susceptibility
regions on at least 15 chromosomes (Bowcock and Cookson,
2004; Lesueur et al., 2007a). Some of these regions have also
been reported to harbor loci for other autoimmune diseases.
For instance, 1q21, 3q21, 17q25, and 20p12 are also linked
to atopic dermatitis (AD), 5q31 is linked to rheumatoid
arthritis, AD and asthma, 16q12 is linked to PsA, systemic
lupus erythematosus, and CD and, finally, 1p13 is linked to
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type I diabetes mellitus, rheumatoid arthritis, systemic lupus
erythematosus, and Graves’ disease (Cookson et al., 2001;
Bowcock, 2005; Yamada and Yamamoto, 2005; Lee et al.,
2007). However, only a few psoriasis susceptibility genes
have been identified to date in these regions, such as LOR at
1q21 (Giardina et al., 2006), SLC12A8 at 3q21 (Hu¨ffmeier
et al., 2005), and ADAM33 at 20p13 (Lesueur et al., 2007b).
As in other complex disorders, the difficulty in identifying
genes that predispose to psoriasis by linkage studies might be
because of the involvement of several low-penetrance genes,
which may interact with each other, with the major gene
HLA-C, or with environmental factors. In an effort to address
this question, we chose to evaluate a list of 22 relevant
candidate genes selected from the literature in a set of
extended French families, in which previous genome-wide
scans had failed to detect any evidence of linkage to these
regions (Lesueur et al., 2007a).
Candidate genes were selected because they had
been associated with skin and immune-mediated disorders
and/or are involved in immune system regulation pathways
(CARD15, CYLD, SLC22A4, SLC9A3R1/NAT9, and RAPTOR)
(Hugot et al., 2001; Helms et al., 2003; Speckman et al.,
2003; Tokuhiro et al., 2003; Reiley et al., 2007), in immune
synapse formation (PTPN22 and SLC9A3R1) (Hasegawa
et al., 2004; Huffmeier et al., 2006), in solute transport
(SLC12A8, SLC22A4, and SLC22A5) (Hewett et al., 2002;
Peltekova et al., 2004), and in inflammatory processes (IL1A,
IL1B, IL1RN, IL1R1, and IL12RB1) (Ravindran et al., 2004;
Peddle et al., 2005; Takahashi et al., 2005). In addition, genes
essential for keratinocyte structural integrity (FLG, TGM1,
TGM3, TGM5, and TGM6) (Russell et al., 1995; Cassidy
et al., 2005; Huffmeier et al., 2007) or genes essential in
epidermal cell homeostasis (STAT3, JUN, and JUNB) (Sano
et al., 2005; Zenz et al., 2005) may have a role in the
susceptibility to this skin disorder and were also investigated.
RESULTS
Single-SNP analysis using the family-based association test,
modified quasi-likelihood score test, and logistic-normal models
To assess the involvement of the 22 candidate genes in
psoriasis, a single-nucleotide polymorphism (SNP) tagging
approach was first undertaken to identify the variation at each
locus. SNPs for which an association with psoriasis or other
skin and autoimmune disorders has been reported in the
literature were also tested. The names, positions, and minor
allele frequencies of the 181 SNPs selected initially for
genotyping in the 45 most informative psoriasis pedigrees,
corresponding to 295 nuclear families, are given in Supple-
mentary Table S1. For all assayed SNPs, genotypes in
founders satisfied criteria for the Hardy–Weinberg equilib-
rium. Overall, the estimates of allele frequencies for SNPs
from parents in nuclear families closely reflected those
reported in the CEU HapMap population.
Single-SNP analysis of the 22 candidate genes was
performed either on the nuclear families (N¼ 295) using
the family-based association test (FBAT), or on the whole
pedigrees (N¼ 45) using the modified quasi-likelihood score
(MQLS). Results for all 153 SNPs genotyped in family Set I are
shown in Supplementary Table S1. With FBAT, the most
significant associations were found for rs1858483 close to
FLG (P¼0.001), and for rs2076752 in the 50UTR of CARD15
(P¼0.005). With MQLS, the most significant associations
were found for rs12925755 close to CYLD (P¼0.005),
for rs2076752 in the 50UTR of CARD15 (P¼ 0.006), for
rs17221417 in intron 2 of CARD15 (P¼ 0.007), and for
rs658971 in intron 8 of SLC12A8 (P¼0.007). A third
approach, the logistic-normal models (LNM) method, was
also applied to the 12 SNPs showing a PFBAT or PMQLSp0.05.
Similar to MQLS, the LNM method also uses the whole
pedigree structure information of the families. LNM results
were in agreement with those obtained with the MQLS
method: we observed a reduced risk of psoriasis for carriers of
the minor alleles of rs315934 (G), rs2076752 (A), rs17221417
(G), and rs2066844 (T) within IL1RN and CARD15
(P¼0.004, 0.003, 0.003, and 0.01, respectively), and an
increased risk of psoriasis for carriers of the minor allele of
rs658971 (A), rs2137599 (C), rs8057341 (A), and rs12925755
(A) within SLC12A8, CARD15, and CYLD (P¼0.009, 0.05,
0.04, and 0.01, respectively) (Table 1, Set I).
With the goal of confirming our findings in a broader
sample set, associated SNPs in Set I were further genotyped in
81 additional French families (Set II). As previously reported
elsewhere, the two family sets were non-homogeneous (see
Materials and Methods section and Lesueur et al., 2007b).
Although Set II presented a lower informativity than Set I,
associations were confirmed in the enlarged sample set for
SNPs within IL1RN and SLC12A8 using at least two of the
three methods, and for SNPs within FLG, CARD15, and
CYLD using FBAT (Table 1, Set Iþ Set II).
Haplotype analysis using the haplotype-based association test
Multi-SNP haplotypes covering whole genes were also tested
for association with psoriasis for the majority of the candi-
dates. However, for FLG, SLC12A8, CARD15, CYLD, and
STAT3, haplotypes could not be constructed because of the
low pairwise LD structure. Therefore, transmissions of all
possible 2-SNP haplotypes to affected individuals were
examined for these five genes. This analysis showed further
evidence for association between psoriasis and FLG,
SLC12A8, CARD15, and CYLD (data not shown), and
revealed association with two additional genes, TGM5 and
STAT3. The TGM5 7-SNP haplotype ACCATGG, with a
frequency of 6.5% in our population, was overtransmitted in
psoriasis patients (PPerm¼ 0.04), and the STAT3 rs1053004/
rs7217655 haplotype CC was undertransmitted in patients
(PPerm¼ 0.03).
Overall, the strongest associations were obtained for
FLG and CARD15. For both genes, the numerous 2-SNP-
haplotypes that were significantly undertransmitted to the
affected family members carried at least one of the SNPs
showing a significant protective effect in the univariate
SNP analysis. For FLG, the best association for increased
protection was obtained for the pair FLG_R501X/rs1858483
(CT haplotype (11%), Z¼ 3.36, PPerm¼0.0008). Similarly,
for CARD15, a significant protective effect was observed
for 2-SNP haplotypes carrying the rare allele (A) of
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rs2076752 (PPermo0.01). A significant risk effect was also
observed for 2-SNP haplotypes carrying the frequent allele
(C) of rs17221417 and the rare allele (A) of rs5743291
(PPermo0.05).
Testing for potential interaction between HLA-Cw6 and the
candidate genes
We have previously reported that the major risk allele HLA-
Cw6 (Asumalahti et al., 2002; Capon et al., 2004) is strongly
associated with psoriasis in the French sample series (Lesueur
et al., 2007b). This robust association previously observed
when using the classical FBAT approach was confirmed with
the LNM or MQLS methods (Supplementary Table S2), thus
validating the power of our family set and the efficiency of
the two latest new approaches to detect association in our
family sample. For example, the highest significant P-values
were obtained for HLA-Cw6 tagging SNPs rs130079 using
LNM (P¼ 6.221015) and rs130076 using MQLS
(P¼2.44 1021).
To investigate a possible interaction between the 153
SNPs and HLA-Cw6, the most informative families (Set I)
were reanalyzed after stratification on the basis of the
presence or absence of the major risk allele. This analysis
showed association for TGM5, CARD15, CYLD, and STAT3
in the subgroup of HLA-Cw6 carriers only, indicating that
HLA-Cw6 is likely to interact with specific alleles of these
genes. Interestingly, although the association between TGM5
and psoriasis was seen only in the multi-SNP haplotype
analysis of Set I, stratification according to the presence of the
HLA-Cw6 allele revealed significant single-SNP associations
for rs2241516, rs11070398, and rs542036 with psoriasis. The
other observed associations were less relevant because of
Table 1. SNP analysis in the extended pedigrees (Set I) and in the combined data set (Set I+Set II) for genes showing
the most significant associations
FBAT MQLS LNM
Set I Set I + Set II Set I Set I + Set II Set I Set I +Set II
Gene1
(chromosomes) SNP ID Region Alleles2 MAF3 N4 Z-value5 P-value6 N4 Z-value5 P-value6 P-value6 P-value6
ORAa
(95% CI)7 P-value6
ORAa
(95% CI)7 P-value6
FLG (1q21) rs1858483 Upstream C4T 13.1 50 3.28 0.001 80 2.61 0.009 0.150 0.264 0.84
(0.59–1.19)
0.336 0.96
(0.74–1.25)
0.780
IL1RN (2q14) rs315934 Intron 1 A4G 19.7 61 0.97 0.331 112 1.20 0.231 0.013 0.012 0.67
(0.51–0.88)
0.004 0.77
(0.63–0.94)
0.012
SLC12A8
(3q21)
rs658971 Intron 8 G4A 21.2 80 1.45 0.146 121 1.46 0.145 0.007 0.002 1.35
(1.08–1.70)
0.009 1.18
(0.98–1.42)
0.082
rs2137599 Intron 2 T4C 43.8 97 2.25 0.025 159 2.47 0.014 0.630 0.341 1.22
(1.00–1.48)
0.047 1.17
(1.00–1.37)
0.046
SLC22A5
(5q31)
rs274559 Intron 3 T4C 36 95 2.03 0.042 151 1.63 0.103 0.630 0.835 0.93
(0.76–1.13)
0.450 0.96
(0.82–1.14)
0.669
CARD15
(16q12)
rs2076752 5’ UTR G4A 33 92 2.79 0.005 156 2.02 0.043 0.006 0.069 0.71
(0.57–0.89)
0.003 0.92
(0.78–1.10)
0.358
rs2111235 Intron 2 C4T 29 92 0.85 0.396 139 0.61 0.540 0.047 0.346 1.23
(0.99–1.51)
0.055 1.05
(0.89–1.25)
0.561
rs8057341 Intron 2 G4A 29.1 92 0.68 0.499 141 0.55 0.583 0.047 0.162 1.25
(1.01–1.54)
0.041 1.08
(0.91–1.27)
0.405
rs17221417 Intron 2 C4G 35.5 91 2.45 0.014 149 1.92 0.055 0.007 0.083 0.71
(0.57–0.89)
0.003 0.92
(0.77–1.09)
0.332
rs2066844
(R702W)
Exon 4 C4T 7.4 31 2.07 0.038 52 0.05 0.960 0.030 0.294 0.56
(0.36–0.88)
0.012 0.85
(0.62–1.16)
0.304
CYLD
(16q12)
rs4785452 Down-
stream
C4T 50.4 104 2.12 0.034 158 2.24 0.025 0.110 0.089 1.10
(0.91–1.34)
0.320 0.93
(0.80–1.08)
0.345
rs12925755 Down-
stream
C4A 33 109 1.04 0.299 ND8 ND ND 0.005 ND 1.33
(1.07–1.65)
0.010 ND ND
Significant P-values (Po0.5) are indicated in bold.
1Reference sequence: NM_002016 for FLG, NM_000577 for IL1RN, NM_024628 for SLC12A8, NM_003060 for SLC22A5, NM_022162 for CARD15,
NM_015247 for CYLD
2Most common allele, according to NCBI, is given first.
3Minor Allele Frequency (%) estimated by FBAT, with minor allele of reference chosen according to NCBI.
4Number of informative nuclear families.
5Score given by the association test for minor allele. A positive Z-value indicates an excess of minor allele transmitted to the affected individuals (increased
risk for psoriasis).
6Association test P-value (not corrected).
7Odds ratio (OR) and 95% confidence interval (95% CI) for the co-dominant model.
8‘‘ND’’ indicates no data.
www.jidonline.org 2639
T Oudot et al.
Shared Genetic Factors in Psoriasis and Autoimmune and Skin Disorders
borderline significance, most probably because of the lack of
informativity of the markers in the two subgroups or the small
sample size (Table 2 and Supplementary Table S3).
DISCUSSION
Genetic analysis of multifactorial diseases is a challenging
task. Nonrandom colocalization of susceptibility loci in
different autoimmune and skin disorders suggests the
presence of common biological pathways or the involvement
of common genetic factors. In this study, we examined 22
candidate genes for psoriasis, some of which had been
reported in the literature to be associated with psoriasis or
other immune-mediated or skin diseases. We chose a large
statistical threshold for suggestive association (5%), taking into
account the risk of obtaining a higher number of false positives.
However, as the 22 investigated genes were tested indepen-
dently for association with psoriasis, gene-specific P-values can
be calculated for each candidate. For example, 10 FLG SNPs
have been genotyped in the highly predisposed family set.
Thus, the best FLG-specific P-value after correction is
0.001*10¼0.01, which is still significant. To confirm sugges-
tive associations, we also analyzed the data with two different
methods that take into account the whole pedigree structure
information in a different manner (MQLS, LNM), and attempted
to confirm initial findings in an enlarged sample set.
In Set I, analysis of the nuclear families with FBAT yielded
evidence for association between psoriasis and FLG,
SLC12A8, TGM5, CARD15, and CYLD. The analyses using
LNM or MQLS confirmed association for the genes SLC12A8,
CARD15, and CYLD, and also revealed an association for
IL1RN. Using an enlarged family set (Set Iþ Set II), associa-
tion was found for five genes with at least one of the methods
(FLG, IL1RN, SLC12A8, CYLD, and CARD15).
For each candidate, we also examined whether the
association with psoriasis was contingent on the presence
of the HLA-Cw6 risk allele. The results after stratification of
the ‘‘high-risk’’ family set according to patient’s HLA-Cw6
status revealed associations for the same genes/SNPs as in the
previous non-stratified analyses, but also revealed some
additional hits such as individual SNPs in the TGM5 gene.
The divergence observed between some results obtained
using the three complementary methods could be due to the
fact that the FBAT method breaks down each pedigree into
nuclear families and treats them independently, whereas the
Table 2. SNP analysis after stratification according to presence or absence of the HLA-Cw6 allele for genes showing
the most significant associations (for Set I)
All patients HLA-Cw6-positive patients HLA-Cw6-negative patients
Gene1 (chromosomes) SNP ID Region Alleles2 MAF3 N4 Z-value5 P-value6 N4 Z-value5 P-value6 N4 Z-value5 P-value6
FLG (1q21) rs1933064 Upstream G4A 42.9 97 1.390 0.17 58 -0.792 0.43 52 2.793 0.005
rs1858483 Upstream C4T 13.1 50 3.285 0.001 26 2.300 0.02 35 2.226 0.02
TGM5 (15q15) rs2241516 Intron 8 G4C 11.8 43 1.427 0.15 27 3.184 0.001 18 1.855 0.06
rs11070398 Intron 5 T4C 13.2 47 1.443 0.15 29 3.095 0.002 22 1.629 0.10
rs542036 Intron 5 T4C 26.5 71 1.357 0.17 43 2.352 0.02 38 0.532 0.60
CARD15 (16q12) rs2076752 5’ UTR G4A 33 92 2.790 0.005 58 2.303 0.02 48 1.514 0.13
rs17221417 Intron 2 C4G 35.5 91 2.447 0.01 58 2.227 0.03 47 1.040 0.30
rs2066844
(R702W)
Exon 4 C4T 7.4 31 2.065 0.04 17 1.389 0.17 19 1.461 0.14
rs7203691 Intron 6 G4A 36.2 107 1.612 0.11 69 2.436 0.01 51 0.359 0.72
rs10521209 Intron 7 T4G 36.5 108 1.462 0.14 70 2.321 0.02 51 0.508 0.61
rs5743291
(V955I)
Exon 9 G4A 10.9 48 1.550 0.12 28 2.939 0.003 26 0.526 0.60
rs3135500 3’ UTR G4A 37.3 108 1.063 0.29 67 2.546 0.01 55 1.290 0.20
CYLD (16q12) rs8056611 Downstream A4G 49.3 106 1.490 0.14 68 2.839 0.005 53 1.040 0.30
rs718226 Downstream A4G 39.4 103 1.476 0.14 64 2.420 0.01 49 0.622 0.53
rs4785452 Downstream C4T 50.4 104 2.123 0.03 68 2.772 0.006 52 0.098 0.92
STAT3 (17q21) rs3869550 Intron 4 A4G 35.9 91 1.252 0.21 57 2.453 0.01 49 0.952 0.34
rs7217655 Intron 4 C4T 34.9 88 1.417 0.16 55 2.586 0.01 48 0.847 0.40
Significant P-values (Po0.5) are indicated in bold.
1Reference sequence: NM_002016 for FLG, NM_004245 for TGM5, NM_022162 for CARD15, NM_015247 for CYLD, and NM_003150 for STAT3.
2Most common allele, according to NCBI, is given first.
3Minor Allele Frequency, estimated by FBAT in the set I, with reference minor allele according to NCBI.
4Number of informative nuclear families.
5Score given by the association test for minor allele.
6P-value (not corrected).
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LNM and MQLS methods take the relationship between all
members of the families into account, avoiding inflated false-
positive rates and increasing the power of the association test
(Xu and Shete, 2007). An advantage of LNM over FBAT or
MQLS is that LNM provides an estimate of the odds ratio.
Although statistical type I errors in Set I cannot be totally
discarded here, the discrepancy between the two family sets
could be accounted for by a lack of informativity of Set II
families. Another possible explanation could be the fact that
the selection of a highly predisposed family enriched Set I for
individuals carrying risk alleles at a smaller number of loci
with stronger effects, whereas psoriasis susceptibility in Set II
may be due to a higher number of loci with weaker effects
(Lesueur et al., 2007b).
Nonetheless, our candidate gene approach led to the
identification of five potential susceptibility genes and the
confirmation of association between SLC12A8 and psoriasis.
SLC12A8 encodes an unknown protein that shares homol-
ogy with cation-chloride-coupled cotransporters (Hewett et al.,
2002). The first evidence of association with psoriasis and
SLC12A8 at the locus PSORS5 (3q21) (Enlund et al., 1999a)
was described in 195 Swedish psoriatic families (Hewett et al.,
2002). Afterward, associations with SCL12A8 intronic SNPs
were found in a German population, independent of the pre-
sence of the PSORS1 risk allele (Hu¨ffmeier et al., 2005). In the
French family series, SLC12A8 was also associated with risk of
psoriasis, although the associations were found on different
intronic SNPs.
IL1RN encodes an antagonist of the pleiotropic pro-
inflammatory cytokine IL-1. It inhibits the binding of IL-1 to
the functional type I IL-1 receptor (IL-1R1) with a complete
lack of receptor activation. Observation of aberrant cytokine
expression in psoriatic patients, as well as evidence for
associations between some of these genes found as a cluster
on chromosome 2q12–14 and psoriasis or PsA, suggests that
the IL-1 system has a probable role in psoriasis (Reich
et al., 2002; Ravindran et al., 2004; Peddle et al., 2005).
Moreover, the transgenic (such as IL-1) and gene knockout
mouse models (such as IL1RN) develop various pathologic
features resembling human psoriasis (Shepherd et al., 2004;
Gudjonsson et al., 2007). In our study, the analyses yielded
evidence for association between psoriasis and the intronic
SNP rs315934, supporting initial findings (Tarlow et al.,
1997), but disagreeing with other recent studies (Reich et al.,
2002; Balding et al., 2003; Chang et al., 2007).
Filaggrin is involved in the terminal differentiation of
epidermis. The FLG gene is located in the epidermal
differentiation complex on 1q21, a susceptibility locus shared
by two inflammatory skin diseases, AD, and psoriasis vulgaris
(Bowcock and Cookson, 2004). Two loss-of-function alleles,
R501X and 2282del4, which lead to premature termination of
profilaggrin translation, cause ichthyosis vulgaris (Sandilands
et al., 2006; Smith et al., 2006) and influence susceptibility to
AD (Palmer et al., 2006). As the 2282del4 null mutation is
too rare (o5%), only R501X was tested in our family set, and
no association with psoriasis susceptibility was observed, in
agreement with other studies (Hu¨ffmeier et al., 2007; Zhao
et al., 2007). However, we found an association, which to our
knowledge was previously unreported, with a common SNP
(rs1858483) situated upstream of FLG.
TGM5 encodes a transglutaminase that crosslinks epi-
dermal proteins such as filaggrin to form the cornified cell
envelope. Recessive loss-of-function mutations in TGM5
have been shown to cause acral peeling skin syndrome, an
autosomal recessive genodermatosis characterized by the
shedding of the outer epidermis (Cassidy et al., 2005). In our
study, only a weak association between TGM5 and psoriasis
was seen in the multi-SNP haplotype analysis, but significant
single-SNP associations for three intronic SNPs of TGM5 with
psoriasis were found in the subgroup of HLA-Cw6 carriers.
A supplementary haplotype analysis after this stratification
revealed a stronger association for the rare haplotype with
psoriasis in the carrier subgroup (PPerm¼0.0002, data not
shown), confirming the interaction between TGM5 and
PSORS1. Thus, our study suggests for the first time a role of
TGM5 in the pathogenesis of psoriasis.
CARD15 and CYLD are adjacent genes on 16q, a
susceptibility locus for PsA and CD (Nair et al., 1997; Hugot
et al., 2001; Karason et al., 2003). Both genes regulate NF-kB
pathways and were found to be independently associated
with psoriasis in our study. In response to bacterial infection,
the product of CARD15 activates the transcription factor
NF-kB, which has a central role in regulating the activation
and homeostasis of T cells (Ogura et al., 2001). The three
non-synonymous SNPs, R702W (rs2066844), G908R
(rs2066845), and L1007fs (rs5743293), have been shown
to confer susceptibility to CD (Hugot et al., 2001; Ogura
et al., 2001). In PsA or psoriasis vulgaris, the results for these
SNPs were controversial (Nair et al., 2001; Borgiani et al.,
2002; Rahman et al., 2003; Young et al., 2003; Giardina
et al., 2004; Plant et al., 2004; Ho et al., 2005; Lascorz et al.,
2005; Jenisch et al., 2006), and only one study undertook a
comprehensive study of the gene (Plant et al., 2004). This
study reveals the association between CARD15 and psoriasis
in large French families, although the association was based
on different SNPs. The coding SNP P268S (rs2066842), which
has been reported to be associated with psoriasis, was not
tested here, but its association is inferred by the results
obtained for rs17221417, with which it is in strong linkage
disequilibrium. A previous study suggested that imprinting at
the 16q locus has a role in susceptibility to psoriasis arthritis
(Karason et al., 2003). The methods employed in this study do
not take the paternal or maternal transmission effects of
CARD15 protective alleles into account. Moreover, using a
classical linkage approach, no significant linkage signal was
observed at the 16q locus containing the gene (Lesueur et al.,
2007a). Therefore, further studies are required to investigate
this possibility.
CYLD is a tumor suppressor gene that is mutated in
familial cylindromatosis, an autosomal dominant genetic
predisposition to multiple tumors of the skin appendages
(Bignell et al., 2000). Although the molecular mechanisms are
not clear, CYLD, a deubiquitinating enzyme, seems to inhibit
the activation of NF-kB in T cells and, therefore, to be a
pivotal protein in the regulation of spontaneous activation and
homeostasis of T cells (Reiley et al., 2007). The spontaneous
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development of the colonic inflammation of Cyld/ mice
and the association of inflammatory bowel diseases with the
reduced expression of CYLD seem to suggest that CYLD has
several biological activities including regulation of the innate
and adaptive immune responses. The two associated SNPs,
rs4785452 and rs12925755, are located 6 and 10kb down-
stream from CYLD, respectively, and they are not in LD with
tested SNPs within CARD15. However, the possibility that
these markers are causal variants affecting CARD15 or CYLD
function or expression cannot be ruled out.
In conclusion, independent confirmation of our findings in
larger sample sets from different populations is required, and
identification of the causal variants for each associated gene
will represent an important development in understanding
susceptibility to psoriasis. More generally, this study provides
evidence for shared genetic factors between psoriasis and other
skin diseases or autoimmune system disorders. Thus, confirmed
genetic risk factors for these diseases falling within specific
biological pathways will offer new possibilities for developing
therapeutics and a rationale for personalized therapies targeted
to different patients based on their genetic information.
MATERIALS AND METHODS
Patients
The 126 French psoriasis families included in this study were
recruited through a media campaign between 1996 and 2001 at
Ge´ne´thon (Mahe´ et al., 2002). The structure of the 126 pedigrees and
the clinical characteristics of the patients have been reported pre-
viously (Lesueur et al., 2007a, b). The families were divided into two
non-homogeneous family sets (Set I and Set II). Set I was composed of
45 high-risk multigenerational families (1161 participants; 8 affected
individuals per family on average) that can be broken down into 295
nuclear families, whereas Set II was composed of 81 smaller families
(668 participants; 3 affected members per family on average) that
corresponds to 173 nuclear families. DNA was extracted from
peripheral blood leukocytes using the standard phenol/chloroform
procedure after written informed consent of participants. The study
was conducted in accordance with the Declaration of Helsinki
Principles and was approved by the Ethics Committee of Le Kremlin-
Biceˆtre Hospital in 1995 (CCPPRB) (Mahe´ et al., 2002).
SNP selection
Single-nucleotide polymorphisms with a minor allele frequency
X5% in Caucasian populations were identified through the HapMap
database. SNPs that efficiently reflect the variation of the remaining
common variations of the candidate genes with r240.8, (that is
‘‘Tagging SNPs’’) were selected with the Haploview software (de
Bakker et al., 2005). In some cases, SNPs that were poorly correlated
with other single SNPs could be efficiently tagged with a haplotype
defined by multiple SNPs. SNPs with ambiguous flanking sequences
were excluded from the study. When coverage with HapMap SNPs
was insufficient, the density of markers was increased by genotyping
additional SNPs reported in the dbSNP database. Moreover, SNPs in
PTPN22, FLG, IL1A, SLC12A8, and CARD15, which had been shown
to be significantly associated with autoimmune or skin disorders in the
literature, were also included in the marker selection process. These
selection approaches resulted in a total set of 153 SNPs that were
genotyped in our family sets (Supplementary Table S1).
SNP genotyping
SNPlex method. Most of the SNP genotyping was performed using
the SNPlex Genotyping System (Applied Biosystems, Foster City, CA),
which enables the simultaneous genotyping of up to 48 SNPs on a
single biological sample. The optimal combination of 48 SNPs to
produce the highest yield per multiplex reaction, and the SNP-Specific
SNPlex probes of 93 SNPs were determined and obtained from Applied
Biosystems online SNP selection Service (through the myScience
Environment Portal at http://myscience.appliedbiosystems.com). Allelic
discrimination was detected using the ABI PRISM 3730XL DNA
Analyzer and GeneMapper Analysis Software v4.0 (Applied Biosystems).
Taqman method. When SNP genotyping could not be achieved
using the SNPlex technology, a Taqman assay was performed
according to the manufacturer’s recommendations (Applied Biosys-
tems, Warrington, UK). Specific SNP probes and primers were
obtained from Applied Biosystems Assay-by-Design Service for SNP
genotyping and are available on request. Allelic discrimination was
performed using the ABI PRISM 7900 HT using the Sequence
Detection Software (SDSv2.0, Applied Biosystems).
Quality control. For each SNP, the Hardy–Weinberg equilibrium
in unrelated unaffected individuals was controlled using the
PEDSTATS procedure, embedded in Merlin (Wigginton and
Abecasis, 2005). Mendelian inheritance errors were checked using
FBAT (Laird et al., 2000). Thirty SNPs did not pass one of the three
quality control tests and were discarded (Supplementary Table S1).
Statistical analysis
Family-based association test. The FBAT test (Laird et al., 2000)
was used to examine the transmission rates of marker alleles, in our
case, under the assumption of no linkage and using an additive
model. The FBAT test is a multiallelic test based on the classic
transmission/disequilibrium test developed by Spielman et al.
(1993). It thus avoids confounding due to model misspecification
as well as admixture or population stratification (Lazzeroni and
Lange, 1998; Rabinowitz and Laird, 2000) and permits analysis of
family structures larger than trios (Lange and Laird, 2002). However,
large pedigrees are broken down into nuclear families and are
treated independently. The pedigree’s contribution to the FBAT test
statistics is then obtained by summing over all nuclear families
within the pedigree. The FBAT program also provides estimates of
allele frequencies for each marker using genotype data from parents
in nuclear families and checks the offspring genotypes of every
nuclear family for any discrepancies from Mendelian laws.
Haplotype analysis was performed using the haplotype-based
association test function of FBAT. This is a method for estimating
genetic association from probabilities of haplotype transmission to
affected offspring. It permits detection of association even at sites
that were not necessarily typed and reveals the SNP combinations
that could contribute to the etiology of the disease. To circumvent
the problem of multiple testing due to the large number of statistical
tests performed simultaneously in the association study, the false
discovery rate was controlled and permutation P-values (PPerm) were
computed with the FBAT program (1,000,000 permutation tests were
performed).
Association was defined by a P-value less than or equal to 0.05.
A Bonferroni correction was not applied for all univariate tests,
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because this correction for multiple testing in association studies
for complex diseases is too conservative, especially when the SNPs
in the candidate regions were partly correlated. Moreover, these
disorders result from the interactions of environmental factors with
multiple genes of which several individual genes have weak effects.
Thus, the weak but real signals could be missed because of the use
of Bonferroni correction.
Modified quasi-likelihood score test
The modified quasi-likelihood score test is a likelihood-based test
applicable to association studies with combinations of family and
case–control designs (Thornton and McPeek, 2007). The method
allows cases to be related to controls and is applicable to com-
plex pedigrees. MQLS incorporates phenotype data about relatives
with missing genotype data. To optimize MQLS power, a specific
k parameter was set at the best estimate of the population disease
prevalence in the population (3–4% for psoriasis in the French
population). However, no differences were observed at different
k parameter specifications. The interpretation of the association
measure is represented by the association test P-value.
Mixed-effects logistic models
Logistic-normal models can be applied to population-based associa-
tion studies with families of different sizes (Xu and Shete, 2007).
This method takes into account the whole family structure including
affected and non-affected individuals. It is indeed important to
account for correlations among family members because identity-by-
descent (IBD) sharing of alleles can inflate the probability of type-I
error and lead to false-positive results (Newman et al., 2001). Each
family defines a cluster and the correlation of family members is
accounted for by the introduction of a corresponding random effect.
This framework thus assumes a natural heterogeneity across families
because of IBD or shared environmental factors. An additive mode
of inheritance was considered, with A as the major allele and a as
the minor allele. We also assumed that there is a specific probability
of being affected in each family, with the effect of the risk locus
being identical across the families, by including only the random
intercept and keeping the effect of the risk locus fixed. The
interpretation of different parameters is analogous to the standard
logistic regression model. Therefore, the transformed regression
coefficient exp (xitb) is the odds of being affected for individuals
with a genotype (Aa or aa) compared with individuals with the
most frequent genotype (AA) as the referent at the risk locus. The
statistical analysis was performed using the R computer package
(version 2.4.1).
Stratification analysis according to HLA-Cw6 status
The four SNPs, HCR-325 C4T (rs130076), HCR-1723 G4T
(rs130079), HCR-2327C4G (rs1576), and CDSN971 C4T
(rs1062470), are in strong linkage disequilibrium with the HLA-
Cw6 risk allele at PSORS1, and the 4-SNP haplotype TTGT provides
an estimate of this allele (Asumalahti et al., 2002; Capon et al.,
2004). Haplotype reconstruction with these four SNPs was
performed in the French family set with the MERLIN program
(Abecasis et al., 2002). We have previously shown that this
haplotype is strongly associated with psoriasis in our family set
(Lesueur et al., 2007b). To investigate a possible interaction between
HLA-Cw6 and SNPs in the candidate genes, affected individuals
were stratified according to the presence or absence of the risk
haplotype, and association between each SNP and psoriasis was
tested in the two groups using FBAT.
Electronic databases and programs
HapMap data are available at http://www.hapmap.org (public data
released in January 2007 for FLG and CYLD, in October 2005 for
JUN, JUNB, and STAT3, and in June 2005 for the other genes). The
dbSNP database is available at http://www.ncbi.nlm.nih.gov/SNP/.
The FBAT program version 1.5.1 is available at http://www.biostat.
harvard.edu/~fbat/. PEDSTATS is available at http://www.sph.umich.
edu/csg/abecasis/PedStats/. The MERLIN program version 1.0.1 is
available at http://www.sph.umich.edu/csg/abecasis/Merlin/. Tagger
on Haploview, version 3.2 is available at http://www.broad.mit.edu/
mpg/haploview/using.php.
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